Codagenix, Inc., has secured an additional $3M in funding in support of its live-attenuated Respiratory Syncytial Virus (RSV) vaccine candidate that was developed in collaboration with National Institute of Allergy and Infectious Diseases (NIAID), a part of NIH.
Learn MoreCFB BEIR-led Traverse Biosciences will enter the exclusive 9-month program which enables participants to establish market and customer relevance, build commercial relationships, and focus on revenue opportunities available to them.
Learn MoreAvanti Biosciences, Inc. a preclinical-stage biopharmaceutical company lead by CFB BioEntrepreneur-in-Residence Dr. Gian Luca Araldi, has announced that the National Institute of Aging (NIA) has awarded the Company an SBIR fast-track grant of up to $1,930,000 to support the company’s small molecule Alzheimer’s disease (AD) over the next 3 years.
Learn MoreThe latest CFB Newsletter has been released – Highlights include major client funding and contracts, the expansion of the LIBH pipeline, and CFB leadership appearing before congress to promote comprehensive, early technology development programs.
Learn MoreCall for Papers: The 13th International Conference & Expo on Emerging Technologies for a Smarter World (CEWIT2017) November 7 & 8, 2017 The Center of Excellence in Wireless and Information Technology (CEWIT) at Stony Brook University Stony Brook, NY, USA …
Learn MoreAwards Support Innovative Research Collaborations Between Academic Faculty and Regional Bioscience Companies The Center for Biotechnology at Stony Brook University has announced the recipients of the 2017-2018 Applied Research & Development (ARAD) awards. The ARAD Program is designed to help …
Learn More